To test whether the UGT2B28-associated tumor growth was reliant on AR signaling, we subcutaneously injected VCaP NT, UGT2B28 KD, and UGT2B28 R cells in castrated mice (Figure 4B). This evidence concerns the gene UGT2B28 and neoplasm.